pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
delpacibart braxlosiran
delpacibart braxlosiran [INN]
Facioscapulohumeral Muscular Dystrophy (FSHD)
Avidity Biosciences Inc
0 catalysts
Phase 3
delpacibart etedesiran
delpacibart etedesiran [INN]
Myotonic Dystrophy
Avidity Biosciences Inc
0 catalysts
Phase 3
deramciclane + dextromethorphan
(deramciclane [INN] + dextromethorphan [INN])
Psychiatric Disorders
Exciva GmbH
0 catalysts
← prev
page 9 of 19
next →
131
Pain89
Neurology1
Phase 3
dersimelagon phosphate
Erythropoietic Protoporphyria
Tanabe Pharma Corp
0 catalysts
Phase 3
deupsilocin besylate
Major Depressive Disorder
HELUS Pharma
0 catalysts
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
Glucocorticoid receptor
$QNCXQuince Therapeutics, Inc.
0 catalysts
Phase 3
diiodothyropropionic acid
Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
Prizm LLC
0 catalysts
Phase 3
direclidine citrate
Schizophrenia
$NBIXNEUROCRINE BIOSCIENCES INC
0 catalysts
Phase 3
divarasib
Non-Small Cell Lung Cancer
Genentech Inc
0 catalysts
Phase 3
dotinurad
dotinurad [INN]
Gouty Arthritis (Gout)
Crystalys Therapeutics Inc
0 catalysts
Phase 3
dulpatatug
dulpatatug [INN]
Adenocarcinoma Of The Gastroesophageal Junction
Shanghai Henlius Biotech Inc
0 catalysts
Phase 3
duvakitug
Crohn's Disease (Regional Enteritis)
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Phase 3
ebselen
ebselen [INN]
Meniere Disease
$SOGPSound Group Inc.
0 catalysts
Phase 3
ecopipam hydrochloride
Tourette Syndrome
Emalex Biosciences Inc
0 catalysts
Phase 3
eflornithine
eflornithine [INN]
Anaplastic Astrocytoma
Orbus Therapeutics Inc
0 catalysts
Phase 3
efmirenpase alfa
efmirenpase alfa [INN]
Arterial Calcification
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Phase 3
efruxifermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Akero Therapeutics Inc
0 catalysts
Phase 3
efsudenermin alfa
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EspeRare Foundation
0 catalysts
Phase 3
eftilagimod alfa
eftilagimod alfa [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$IMMPIMMUTEP Ltd
0 catalysts
Phase 3
efzimfotase alfa
Hypophosphatasia
Alexion Pharmaceuticals Inc
0 catalysts
Phase 3
elebsiran
Hepatitis D
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 3
elebsiran + tobevibart
Hepatitis D
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 3
elegrobart
Graves' Ophthalmopathy
Viridian Therapeutics Inc
0 catalysts
Phase 3
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
0 catalysts
Phase 3
elfucose
Inherited Metabolic Disorders
AUG Therapeutics LLC
0 catalysts
Phase 3
elritercept
Anemia
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
elsunersen
elsunersen [INN]
Epileptic Encephalopathy
$PRAXPraxis Precision Medicines, Inc.
0 catalysts
Phase 3
emactuzumab
Tenosynovial Giant Cell Tumor
Macrophage colony-stimulating factor 1 receptor
SynOx Therapeutics Ltd
0 catalysts
Phase 3
emestedastat
Xanamem (emestedastat)
Alzheimer's Disease
Actinogen Medical Ltd
0 catalysts
Phase 3
emixustat hydrochloride
Juvenile Macular Degeneration (Stargardt Disease)
Retinoid isomerohydrolase
Kubota Vision Inc
0 catalysts